Skip to main content

QD Clinic - Audience RA Questions from RNL23

May 01, 2023 2:31 pm

Audience Questions & Answers from RNL23 on Rheumatoid Arthritis

RNL23 was Sponsored by Abbvie – Thanks to Abbvie for their support of Rheumatology Education!

RA: Revolutionary Advances in Therapy This POD (session) devoted to advances in rheumatoid arthritis (RA) featured three excellent lectures:

- Dr. Kevin Deane – Preclinical RA – to Treat or not to treat

- Dr. Stanley Cohen – Year of the JAK inhibitors

- Dr. Michael Brenner - “Fibroblasts: Stromal Cells that hold exciting promise for treating RA.

Disclosures

Disclosures
The author has received compensation as an advisor or consultant on this subject

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×